AcelRx Pharma (ACRX) Gets U.S. Patent for 'Small-Volume Oral Transmucosal Dosage Forms'
Go back to AcelRx Pharma (ACRX) Gets U.S. Patent for 'Small-Volume Oral Transmucosal Dosage Forms'| ACELRX PHARMA (NASDAQ: ACRX) | Delayed: 0.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $5.88 | |||
| Open | $0.25 | 52 Week Low | $2.40 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.86 | EPS | $-1.50 | |||
| Volume | 8 | |||||
